Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension

Benzer Materyaller

• The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
  Yazar:: Radcliffe, Nathan M
  Baskı/Yayın Bilgisi: (2014)
• Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
  Yazar:: Ichhpujani, Parul, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
  Yazar:: Inoue, Kenji, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
  Yazar:: Baiza-Durán, Leopoldo Martín, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
  Yazar:: Aihara, Makoto, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)